Farmaceutica Remedia (BSE:RMAH) Cash-to-Debt : 20.31 (As of Sep. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Farmaceutica Remedia's cash to debt ratio for the quarter that ended in Sep. 2024 was 20.31.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Farmaceutica Remedia could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Farmaceutica Remedia's Cash-to-Debt or its related term are showing as below:

BSE:RMAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.13 Med: 24.56 Max: No Debt
Current: 20.31

During the past 13 years, Farmaceutica Remedia's highest Cash to Debt Ratio was No Debt. The lowest was 0.13. And the median was 24.56.

BSE:RMAH's Cash-to-Debt is ranked better than
88.07% of 109 companies
in the Medical Distribution industry
Industry Median: 0.79 vs BSE:RMAH: 20.31

Farmaceutica Remedia Cash-to-Debt Historical Data

The historical data trend for Farmaceutica Remedia's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Farmaceutica Remedia Cash-to-Debt Chart

Farmaceutica Remedia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

5.66

39.57

18.09

15.08

16.18

Farmaceutica Remedia Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															10.98	16.18	25.12	27.86	20.31

Competitive Comparison of Farmaceutica Remedia's Cash-to-Debt

For the Medical Distribution subindustry, Farmaceutica Remedia's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farmaceutica Remedia's Cash-to-Debt Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Cash-to-Debt falls into.

Farmaceutica Remedia Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Farmaceutica Remedia's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	34.498	/	(0.932	+	1.2)
	=	16.18

Farmaceutica Remedia's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	31.505	/	(0.876	+	0.675)
	=	20.31

Farmaceutica Remedia (BSE:RMAH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Farmaceutica Remedia Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Farmaceutica Remedia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040

Website

https://corporate.remedia.ro

Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia Headlines

No Headlines